AVILA THERAPEUTICS INC

Profile

Company Names

AVILA THERAPEUTICS INC

Addresses

100 BEAVER STREET, WALTHAM, MA 02453

Phone Numbers

781-891-0086

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2006

State Incorporated:

DE

Total Amount Raised:

$27,500,000.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2009-07-16 
$22,500,000.00 
$30,000,000.00 
$7,500,000.00 
Equity 
1
2009-04-29 
$5,000,000.00 
$20,000,000.00 
$15,000,000.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MICHAEL 
F. 
BIGHAM 
EXECUTIVE OFFICER, DIRECTOR
AVILA THERAPEUTICS INC   |  SECURE EDI HOLDINGS, LLC
BRUCE 
 
BOOTH 
DIRECTOR
MIRAGEN THERAPEUTICS INC   |  AVILA THERAPEUTICS INC   |  ZAFGEN, INC.   |  NIMBUS DISCOVERY, LLC   |  ON-Q-ITY, INC.   |  NUMERATE INC   |  UNUM THERAPEUTICS, INC.   |  LYSOSOMAL THERAPEUTICS, INC.   |  AVROBIO, INC.   |  MAGENTA THERAPEUTICS, INC.   |  ATLAS VENTURE FUND XI, L.P.   |  RODIN THERAPEUTICS, INC.   |  ATLAS VENTURE OPPORTUNITY FUND I, L.P.   |  ATLAS VENTURE FUND XII, L.P.   |  VIGIL NEUROSCIENCE, INC.   |  ATLAS VENTURE OPPORTUNITY FUND II, L.P.   |  ATLAS VENTURE FUND XIII, L.P.   |  MATCHPOINT THERAPEUTICS INC.   |  ATLAS VENTURE FUND XIV, L.P.   |  ATLAS VENTURE OPPORTUNITY FUND ILL, L.P.
KATRINE 
 
BOSLEY 
EXECUTIVE OFFICER, DIRECTOR
AVILA THERAPEUTICS INC   |  GENOCEA BIOSCIENCES, INC.   |  EDITAS MEDICINE, INC.   |  SCHOLAR ROCK LLC
ROY 
R. 
LOBB 
EXECUTIVE OFFICER, DIRECTOR
AVILA THERAPEUTICS INC   |  MERCATOR THERAPEUTICS, INC.
DANIEL 
 
LYNCH 
EXECUTIVE OFFICER, DIRECTOR
AVILA THERAPEUTICS INC   |  STROMEDIX INC   |  BLUEPRINT MEDICINES CORP   |  RANA THERAPEUTICS, LLC   |  PROCLARA BIOSCIENCES, INC.   |  RANA THERAPEUTICS, INC.   |  SPRINGWORKS THERAPEUTICS, LLC   |  XILIO THERAPEUTICS, INC.   |  2SEVENTY BIO, INC.   |  CARDURION PHARMACEUTICALS, INC.   |  GU CAPITAL LP
AMIR 
 
NASHAT 
DIRECTOR
PROMEDIOR INC   |  AVILA THERAPEUTICS INC   |  PERVASIS THERAPEUTICS INC   |  FATE THERAPEUTICS INC   |  BIND BIOSCIENCES INC   |  SELECTA BIOSCIENCES INC   |  POLARIS VENTURE PARTNERS VI, L.P.   |  SUN CATALYTIX CORP   |  RECEPTOS, INC.   |  POLARIS ENTREPRENEURS- FUND VII, L.P.   |  POLARIS PARTNERS VII, L.P.   |  ATYR PHARMA INC   |  AGBIOME, LLC   |  METACRINE, INC.   |  SCHOLAR ROCK LLC   |  1366 TECHNOLOGIES INC   |  SOFREGEN MEDICAL INC.   |  POLARIS ENTREPRENEURS- FUND VIII, L.P.   |  SYROS PHARMACEUTICALS, INC.   |  SCHOLAR ROCK HOLDING CORP   |  CAMP4 THERAPEUTICS CORP   |  MORPHIC HOLDING, LLC   |  FREENOME HOLDINGS, INC.   |  PRIMMUNE THERAPEUTICS, INC.   |  MORPHIC HOLDING, INC.
RAJ 
 
PAREKH 
DIRECTOR
AVILA THERAPEUTICS INC   |  PRANALYTICA INC   |  ARTAX BIOPHARMA, INC.   |  MACROLIDE PHARMACEUTICALS, INC.   |  ARRAKIS THERAPEUTICS, INC.
VICKI 
 
SATO 
DIRECTOR
AVILA THERAPEUTICS INC   |  NIMBUS DISCOVERY, LLC   |  NEUROPHAGE PHARMACEUTICALS INC   |  SYROS PHARMACEUTICALS, INC.   |  VIR BIOTECHNOLOGY, INC.   |  AKOUOS, INC.
HENRY 
 
SKINNER 
DIRECTOR
AVILA THERAPEUTICS INC   |  THESAN PHARMACEUTICALS, INC.   |  AEGLEA BIOTHERAPEUTICS HOLDINGS, LLC   |  GALERA THERAPEUTICS, INC.   |  AEGLEA BIOTHERAPEUTICS, INC.   |  PROTEOSTASIS THERAPEUTICS, INC.   |  MACROLIDE PHARMACEUTICALS, INC.   |  CAVION, INC.   |  NEUROVIA, INC.   |  GENOMEDX INC.   |  CURASEN THERAPEUTICS, INC.   |  DECIPHER BIOSCIENCES, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2010-07-06
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-07-16 
2009-07-31
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2009-07-16 
2009-05-14
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Debt 
2009-04-29 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#